Compare Cintas Corporation (CTAS) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cintas Corporation vs Ginkgo Bioworks Holdings Inc — how do they compare? Cintas Corporation trades at $205.28 (market cap $82.15B), while Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M). The key difference: Cintas Corporation is far larger — about 162.4× Ginkgo Bioworks Holdings Inc's market cap, and Cintas Corporation pays a 1.01% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| CTAS | DNA | |
|---|---|---|
Market Cap | $82.15B | $505.73M |
Sector | Industrials | Health |
52-Week High | $225.10 | $16.14 |
52-Week Low | $163.55 | $5.48 |
Enterprise Value | $84.56B | $607.68M |
Dividend Yield | 1.01% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cintas Corporation
In its core uniform and facility services unit (78% of sales), Cintas provides uniform rental programs to businesses across the size spectrum, mostly in North America. The firm is by far the largest provider in the industry. Facilities products generally include the rental and sale of entrance mat, mops, shop towels, hand sanitizers, and restroom supplies. Cintas also runs a first aid and safety services business (11% of sales), a fire protection services business (7% of sales), and a uniform direct sales business (4% of sales).
Read more on CTAS →About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →
